$9.88-0.08|(-0.80%)
52W H: 11.5852W L: 4.79Beta: 1.02

About Senseonics Holdings Inc

Frequently Asked Questions

What is the 52-week range for SENS?

The 52-week high is $11.58 and the 52-week low is $4.79.

What is the P/E ratio for SENS?

The P/E ratio data is currently unavailable.

What is the dividend yield for SENS?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is -165.83%.

What is the Net Profit Margin?

The Net Profit Margin (TTM) is -225.34%.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 3.69.

Analyst Recommendation Trends

Wall Street analyst consensus for SENS over the last few months:

2026-09-01
Buy: 7
S.Buy: 2
Hold: 3
Sell: 1
2026-08-01
Buy: 7
S.Buy: 2
Hold: 3
Sell: 1
2026-07-01
Buy: 7
S.Buy: 2
Hold: 3
Sell: 1
2026-06-01
Buy: 7
S.Buy: 2
Hold: 3
Sell: 1

Latest SENS News

Beta Bionics Stock Down Despite iLet-Eversense 365 Integration Deal

BBNX's Eversense 365 partnership is likely to broaden CGM choice and strengthen its automated insulin delivery ecosystem across iLet and mint.

Yahoo9/29/2026

Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the iLet® Bionic Pancreas

Pairing year-long continuous glucose monitoring with automated insulin delivery to further simplify diabetes management for patients Brings Eversense 365 to the growing community of iLet Bionic Pancreas users Plan for commercial launch of the integrated system in Q4 2026 GERMANTOWN, Md., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), maker of the Eversense 365 Continuous Glucose Monitoring (CGM) System, the world’s first and only long-term, one-year implantable sens

Yahoo9/14/2026

Senseonics Partners With Beta Bionics To Integrate Its Eversense 365 CGM With Beta Bionics’ iLet Bionic Pancreas Automated Insulin Delivery System

The companies are collaborating to integrate Eversense® 365 CGM with Beta Bionics’ iLet® Bionic Pancreas automated insulin delivery (AID) system designed to simplify diabetes management. The integrated device will aim

Benzinga9/14/2026

Senseonics To Participate in Upcoming Institutional Investor Conferences

GERMANTOWN, Md., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in two upcoming investor conferences. Details on the Company’s participation appear below: Lake Street 10th Annual Big Ideas Growth Conference – September 10, 2026 (New York, NY)Management will host o

Yahoo9/10/2026

Related Stocks (Peers)

Companies operating in similar sectors to SENS:

Recent Insider Transactions

DateNameShares ChangedPriceValue
2026-08-19ROEDER DOUGLAS A+13,953$8.98$125,298
2026-07-01Steven Edelman+2,402$5.36$12,875
2026-07-01Prince Douglas S+1,515$5.36$8,120
2026-07-01Fiorentino Edward+2,635$5.36$14,124
2026-07-01ROEDER DOUGLAS A+2,751$5.36$14,745
2026-06-15Sullivan Frederick T.-5,397$7.18$38,750
2026-06-15Kaufman Francine-4,010$7.18$28,792
2026-06-15JAIN Mukul-16,194$7.18$116,273
2026-06-15Goodnow Timothy T-32,598$7.18$234,054
2026-06-15Horton Kenneth L-9,545$7.18$68,533
2026-06-15HANSEN BRIAN B-5,420$7.18$38,916
2026-05-20Larkin Sharon+13,574--
2026-05-20Larkin Sharon+9,852--
2026-05-20Steven Edelman+13,574--
2026-05-20Steven Edelman+9,852--
2026-05-20Prince Douglas S+13,574--
2026-05-20Prince Douglas S+9,852--
2026-05-20Fiorentino Edward+13,574--
2026-05-20Fiorentino Edward+9,852--
2026-05-20DeFalco Stephen P+13,574--
2026-05-20DeFalco Stephen P+9,852--
2026-05-20ROEDER DOUGLAS A+13,574--
2026-05-20ROEDER DOUGLAS A+9,852--
2026-05-19Sullivan Frederick T.+124,193--
2026-05-19Sullivan Frederick T.+90,253--
2026-05-19Kaufman Francine+86,935--
2026-05-19Kaufman Francine+63,177--
2026-05-19JAIN Mukul+372,579--
2026-05-19JAIN Mukul+270,759--
2026-05-19Goodnow Timothy T+761,923--
2026-05-19Goodnow Timothy T+553,701--
2026-05-19Horton Kenneth L+217,338--
2026-05-19Horton Kenneth L+157,943--
2026-05-19HANSEN BRIAN B+124,193--
2026-05-19HANSEN BRIAN B+90,253--
2026-05-15Sullivan Frederick T.-9,005$5.82$52,409
2026-05-15Kaufman Francine-6,058$5.82$35,258
2026-05-15JAIN Mukul-13,681$5.82$79,623
2026-05-15Goodnow Timothy T-28,598$5.82$166,440
2026-05-15Horton Kenneth L-7,320$5.82$42,602
2026-05-12ROEDER DOUGLAS A+22,686$5.56$126,134
2026-04-01Steven Edelman+1,936$6.65$12,874
2026-04-01Prince Douglas S+1,221$6.65$8,120
2026-04-01Fiorentino Edward+2,124$6.65$14,125
2026-04-01ROEDER DOUGLAS A+2,218$6.65$14,750
2026-03-13Goodnow Timothy T+17,225$5.79$99,733
2026-03-13ROEDER DOUGLAS A+17,500$5.73$100,275
2026-01-02Steven Edelman+2,185$5.89$12,870
2026-01-02Prince Douglas S+1,379$5.89$8,122
2026-01-02Fiorentino Edward+2,398$5.89$14,124
2026-01-02ROEDER DOUGLAS A+2,504$5.89$14,749
2025-11-15Sullivan Frederick T.-6,402$6.26$40,077
2025-11-15Kaufman Francine-4,605$6.26$28,827
2025-11-15JAIN Mukul-10,317$6.26$64,584
2025-11-15Goodnow Timothy T-27,067$6.26$169,439
2025-11-15Horton Kenneth L-5,997$6.26$37,541
2025-11-10Steven Edelman+10,000$6.55$65,500
2025-11-07Sullivan Frederick T.+5,415$5.88$31,840
2025-11-07Goodnow Timothy T-17,210$5.87$101,023
2025-11-07ROEDER DOUGLAS A+15,000$5.83$87,450